The recommended dose for adults is 1200 mg administered in two divided doses 30 minutes before the morning and evening meals (see CLINICAL PHARMACOLOGY).
There have been reported cases of overdosage with gemfibrozil. In one case, a 7-year-old child recovered after ingesting up to 9 grams of gemfibrozil. Symptoms reported with overdosage were abdominal cramps, abnormal liver function tests, diarrhea, increased CPK, joint and muscle pain, nausea and vomiting. Symptomatic supportive measures should be taken, should an overdose occur.
Gemfibrozil Tablets, USP are supplied as White film-coated tablets, capsule-shaped, biconvex tablets; Debossed with “I” on the left side of the bisect and “G” on the right side of the bisect on one side and “225″ on the other, and available as follows:
NDC 51138-588-30 Bottles of 30
Store at controlled room temperature 20° — 25°C (68° — 77°F) [see USP]. Protect from light and humidity.
InvaGen Pharmaceuticals, Inc.
Hauppauge, NY 11788
West-ward Pharmaceutical Corp.
Eatontown, NJ 07724
Med-Health Pharma, LLC
North Las Vegas, NV 89032
Gemfibrozil Tablets, USP 600 mg
|GEMFIBROZIL gemfibrozil tablet, film coated|
|Labeler — Med-Health Pharma, LLC (962603812)|
|Med-Health Pharma, LLC||962603812||repack|
Revised: 07/2011 Med-Health Pharma, LLC
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.